First Horizon Advisors’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-25
Closed -$13K 1900
2020
Q4
$13K Hold
25
﹤0.01% 994
2020
Q3
$16K Hold
25
﹤0.01% 884
2020
Q2
$19K Hold
25
﹤0.01% 816
2020
Q1
$14K Buy
25
+9
+56% +$8.77K ﹤0.01% 849
2019
Q4
$18K Hold
16
﹤0.01% 888
2019
Q3
$18K Hold
16
﹤0.01% 876
2019
Q2
$25K Hold
16
﹤0.01% 791
2019
Q1
$32K Hold
16
﹤0.01% 643
2018
Q4
$20K Buy
+16
New +$24.5K ﹤0.01% 792

Other funds holding BLUE

First Horizon Advisors's BLUE Position: Q1 2021 in Review

First Horizon Advisors sold out of bluebird bio (BLUE) in Q1 2021, closing a stake of 25 shares — an estimated $13K sold.

First Horizon Advisors first reported a position in BLUE in Q4 2018 and held it in 9 quarters. The position peaked at $32K in Q1 2019. 229 funds tracked by Wall St. Rank hold BLUE as of Q1 2021.

  • First Horizon Advisors reported no remaining bluebird bio position as of Q1 2021 after selling out during the quarter.
  • First Horizon Advisors sold 25 bluebird bio shares in Q1 2021, an estimated $13K.
  • First Horizon Advisors first reported a position in bluebird bio in Q4 2018 and held it in 9 quarters.
  • First Horizon Advisors's bluebird bio position peaked at $32K in Q1 2019.
  • 229 funds tracked by Wall St. Rank held bluebird bio as of Q1 2021.

Based on First Horizon Advisors's 13F filing for Q1 2021, filed 11 May 2021.